Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.

por Keith, W. N., Stallard, S., Brown, R.
Publicado 1990

Targeting telomerase for cancer therapeutics

por Shay, J W, Keith, W N
Publicado 2008

Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity.

por McLeod, H. L., Keith, W. N.
Publicado 1996

Retrovirus mediated transfer and expression of GM-CSF in haematopoietic cells.

por Keith, W. N., Brown, R., Pragnell, I. B.
Publicado 1990

Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.

por Coutts, J., Plumb, J. A., Brown, R., Keith, W. N.
Publicado 1993

High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma

por Cairney, C J, Hoare, S F, Daidone, M-G, Zaffaroni, N, Keith, W N
Publicado 2008

Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage

por Russell, A J, Sibbald, J, Haak, H, Keith, W N, McNicol, A M
Publicado 1999

Identification of genetic changes associated with drug resistance by reverse in situ hybridization.

por Hoare, S. F., Freeman, C. A., Coutts, J. C., Varley, J. M., James, L., Keith, W. N.
Publicado 1997

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.

por Withoff, S., Keith, W. N., Knol, A. J., Coutts, J. C., Hoare, S. F., Mulder, N. H., de Vries, E. G.
Publicado 1996

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

por Withoff, S., de Vries, E. G., Keith, W. N., Nienhuis, E. F., van der Graaf, W. T., Uges, D. R., Mulder, N. H.
Publicado 1996